Literature DB >> 16163486

The role of chromatin proteins in DNA damage recognition and repair.

Piotr Widlak1, Monika Pietrowska, Joanna Lanuszewska.   

Abstract

The structure of chromatin is the major factor determining the rate and efficiency of DNA repair. Chromatin remodeling events such as rearrangement of nucleosomes and higher order chromatin structures are indispensable features of repair processes. During the last decade numerous chromatin proteins have been identified that preferentially bind to different types of DNA damage. The HMGB proteins, which preferentially interact with DNA intrastrand crosslinks induced by cisplatin, are the archetypal example of such proteins. Several hypothetical models have been proposed describing the role of such damage-binding chromatin proteins. The damage shielding model postulates that binding of chromatin proteins to damaged DNA might disturb damage recognition by repair factors and impair its removal. Alternatively, the damage-recognition/signaling model proposes that the binding of specific chromatin proteins to damaged DNA could serve as a hallmark to be recognized by repair proteins. Additionally, the binding of specific chromatin proteins to damaged DNA could induce chromatin remodeling at the damage site and indirectly affect its repair. This paper aims to critically review current experimental data in relation to such possible roles of chromatin proteins.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16163486     DOI: 10.1007/s00418-005-0053-5

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  80 in total

Review 1.  Repair of DNA lesions in chromosomal DNA impact of chromatin structure and Cockayne syndrome proteins.

Authors:  Maria Fousteri; Anneke van Hoffen; Hana Vargova; Leon H F Mullenders
Journal:  DNA Repair (Amst)       Date:  2005-07-28

2.  NBS1 localizes to gamma-H2AX foci through interaction with the FHA/BRCT domain.

Authors:  Junya Kobayashi; Hiroshi Tauchi; Shuichi Sakamoto; Asako Nakamura; Ken-ichi Morishima; Shinya Matsuura; Toshiko Kobayashi; Katsuyuki Tamai; Keiji Tanimoto; Kenshi Komatsu
Journal:  Curr Biol       Date:  2002-10-29       Impact factor: 10.834

3.  Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins.

Authors:  U M Ohndorf; M A Rould; Q He; C O Pabo; S J Lippard
Journal:  Nature       Date:  1999-06-17       Impact factor: 49.962

4.  Steroid hormones induce HMG1 overexpression and sensitize breast cancer cells to cisplatin and carboplatin.

Authors:  Q He; C H Liang; S J Lippard
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

5.  Chromosomal protein HMGN1 enhances the rate of DNA repair in chromatin.

Authors:  Yehudit Birger; Katherine L West; Yuri V Postnikov; Jae-Hwan Lim; Takashi Furusawa; James P Wagner; Craig S Laufer; Kenneth H Kraemer; Michael Bustin
Journal:  EMBO J       Date:  2003-04-01       Impact factor: 11.598

6.  Histone H2AX phosphorylation is dispensable for the initial recognition of DNA breaks.

Authors:  Arkady Celeste; Oscar Fernandez-Capetillo; Michael J Kruhlak; Duane R Pilch; David W Staudt; Alicia Lee; Robert F Bonner; William M Bonner; André Nussenzweig
Journal:  Nat Cell Biol       Date:  2003-07       Impact factor: 28.824

7.  Mutagenesis of the HMGB (high-mobility group B) protein Cmb1 (cytosine-mismatch binding 1) of Schizosaccharomyces pombe: effects on recognition of DNA mismatches and damage.

Authors:  Christophe Kunz; Karin Zurbriggen; Oliver Fleck
Journal:  Biochem J       Date:  2003-06-01       Impact factor: 3.857

8.  HMG-domain proteins specifically inhibit the repair of the major DNA adduct of the anticancer drug cisplatin by human excision nuclease.

Authors:  J C Huang; D B Zamble; J T Reardon; S J Lippard; A Sancar
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

9.  Evidence for involvement of HMGB1 protein in human DNA mismatch repair.

Authors:  Fenghua Yuan; Liya Gu; Shuangli Guo; Chunmei Wang; Guo-Min Li
Journal:  J Biol Chem       Date:  2004-03-09       Impact factor: 5.157

10.  Binding of Ixr1, a yeast HMG-domain protein, to cisplatin-DNA adducts in vitro and in vivo.

Authors:  M M McA'Nulty; J P Whitehead; S J Lippard
Journal:  Biochemistry       Date:  1996-05-14       Impact factor: 3.162

View more
  7 in total

1.  Downregulation of SWI/SNF chromatin remodeling factor subunits modulates cisplatin cytotoxicity.

Authors:  Anbarasi Kothandapani; Kathirvel Gopalakrishnan; Bhaskar Kahali; David Reisman; Steve M Patrick
Journal:  Exp Cell Res       Date:  2012-06-18       Impact factor: 3.905

Review 2.  The histochemistry and cell biology vade mecum: a review of 2005-2006.

Authors:  Douglas J Taatjes; Christian Zuber; Jürgen Roth
Journal:  Histochem Cell Biol       Date:  2006-11-24       Impact factor: 4.304

Review 3.  Recent progress in histochemistry.

Authors:  Christian Zuber; Douglas J Taatjes; Jürgen Roth
Journal:  Histochem Cell Biol       Date:  2007-10-31       Impact factor: 4.304

Review 4.  Histone modifications and DNA double-strand break repair after exposure to ionizing radiations.

Authors:  Clayton R Hunt; Deepti Ramnarain; Nobuo Horikoshi; Puneeth Iyengar; Raj K Pandita; Jerry W Shay; Tej K Pandita
Journal:  Radiat Res       Date:  2013-02-01       Impact factor: 2.841

5.  Characterization of histone modifications associated with DNA damage repair genes upon exposure to gamma rays in Arabidopsis seedlings.

Authors:  Suvendu Mondal; Young Sam Go; Seung Sik Lee; Byung Yeoup Chung; Jin-Hong Kim
Journal:  J Radiat Res       Date:  2016-08-16       Impact factor: 2.724

Review 6.  Chromatin Remodeling and Epigenetic Regulation in Plant DNA Damage Repair.

Authors:  Jin-Hong Kim
Journal:  Int J Mol Sci       Date:  2019-08-22       Impact factor: 5.923

7.  Chromatin modifications and the DNA damage response to ionizing radiation.

Authors:  Rakesh Kumar; Nobuo Horikoshi; Mayank Singh; Arun Gupta; Hari S Misra; Kevin Albuquerque; Clayton R Hunt; Tej K Pandita
Journal:  Front Oncol       Date:  2013-01-22       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.